United States Patent 8,734,394: Scope, Claim Architecture, and US Patent Landscape
US Patent 8,734,394 is directed to an injection apparatus delay mechanism that coordinates (1) needle extension and plunger-driven injection with (2) a timed/unlatched transition to retraction. The core claim language centers on a latching-and-locking architecture between a shuttle and a follower, a locking member that prevents follower rotation during injection, damping of follower rotation, and a dual-function biasing member that provides both torsional preloading and axial preloading in a sequence triggered by release of the locking member.
The claims you provided define a multi-stage mechanical timing system rather than a chemical or therapeutic composition claim set. The practical scope is therefore tied to: (i) the mechanical sequence (latching to unlatching, then axial retraction), (ii) the interaction points (locking member engagement with syringe plunger and cooperation between latching elements), and (iii) the specific functional coupling of a biasing member that acts both torsionally and axially between shuttle and follower.
What is Claim 1 actually claiming? (mechanism + sequencing + conditional behavior)
Independent claim 1 defines the delay mechanism as part of an automatic injection apparatus that contains:
- a housing
- a needle-bearing syringe with a plunger
- at least one biasing element that moves the syringe needle forward and advances the plunger during injection
Within that apparatus, claim 1 adds a delay mechanism with these subassemblies and functional requirements:
1) Shuttle and follower with opposing latching elements
- A shuttle includes a first latching element.
- A follower includes a second latching element.
- The first and second latching elements cooperate to “limit motion of said shuttle relative to said follower in a second direction opposite the first direction.”
The second direction is the direction toward retraction, so the latching system is positioned to prevent premature relative movement that would otherwise retract the needle/shift the syringe assembly before the intended injection completes.
2) A locking member that blocks follower rotation during injection
- The locking member is movable within the housing from a locking position to a release position by engagement with the syringe plunger during injection.
- When in locking position, it prevents rotation of the follower relative to the shuttle.
- When in release position, it allows rotation of the follower relative to the shuttle.
This is a sequencing constraint: even if the biasing elements try to move components, follower rotation is inhibited until the locking member shifts during the injection event.
3) Damping compound between follower and supporting surface
- A damping compound is between the follower and a supporting surface to dampen rotation of the follower relative to the shuttle.
This is not just “friction”; it specifies a damping compound used to control rotational dynamics at the follower rotation stage.
4) A dual-function biasing member with torsional and axial preloading
The center of gravity in claim 1 is the dual functioning biasing member that:
- has torsional preloading
- has axial preloading
- acts between the shuttle and follower
- provides:
- a torsional force urging the follower to rotate relative to the shuttle
- an axial force urging the shuttle away from the follower
5) Required two-step actuation sequence on release
Claim 1 imposes a functional ordering:
When the locking member moves to release position during injection:
1) the dual biasing member first forces the follower to rotate relative to the shuttle:
- from a latching position (first and second latching elements engaged)
- to an unlatching position (second latching element disengaged)
2) then the same dual biasing member forces the shuttle axially relative to the follower:
- moving the shuttle to retract the syringe needle into the housing after injection
This is a stringent sequencing limitation. Mechanisms that unlatch and then retract using independent springs (or where torsional action does not precede axial action) will tend to fall outside claim 1’s required “first… and then…” functional behavior.
How do the dependent claims narrow the structure?
Claim 2: Dual-function biasing member is a coiled spring
Claim 2 limits the dual functioning biasing member to “a coiled spring” with first and second ends that directly engage the follower and shuttle respectively.
Scope impact:
- “Dual functioning biasing member” is no longer broad to other torsion/axial energy storage devices.
- Only a coiled spring with end engagements meets this narrowing.
Claim 3: First end has a radially outward tip fitting in follower recess
- The coiled spring first end includes a radially outwardly extending tip.
- The tip fits within a complementarily shaped recess formed by an opening through a body of the follower.
Scope impact:
- It requires a specific geometric interface (radial tip + through-body recess in the follower).
Claim 4: Second end has an axially extending tip fitting in shuttle recess
- The coiled spring second end includes an axially extending tip.
- It fits within a complementarily shaped recess in the shuttle.
Scope impact:
- Adds second geometric interface requiring an axial tip and matching recess.
Claim 5: The shuttle recess is formed in a radially projecting tab that comprises the first latching element
- The recess formed in the shuttle is formed in a radially projecting tab.
- That tab comprises the first latching element.
Scope impact:
- Ties the latch element to the recess geometry, narrowing the shuttle structure.
Claim 6: Supporting surface is a collar rotatably fixed to the housing
- Supporting surface comprises a surface of a collar rotatably fixed relative to the housing.
Scope impact:
- Defines the rotational support interface for damping (collar-based support).
Claim 7: Locking member comprises flexures integrally formed with the follower
- Locking member comprises at least one flexure integrally formed with the follower.
- Flexure is axially movable relative to the shuttle by engagement with an outrigger of the syringe plunger.
- Moves between locking and release positions.
Scope impact:
- Locks into a particular locking member implementation: follower-integral flexures, axially moved by an outrigger on the syringe plunger.
Claim 8: Biasing for retracting is not resisted by the forward-driving biasing element
- Shuttle comprises a support against which acts the biasing element that moves the needled syringe and advances the plunger.
- Biasing of the shuttle for retracting is not resisted by the biasing element that advances the plunger.
Scope impact:
- Addresses force-path independence: the retract phase is not mechanically countered by the injection-driving biasing element.
Where is the likely “scope boundary”? (what implementations are most likely outside)
Based on the claim language provided, the strongest exclusion zones are:
1) No conditional follower rotation gating
- If the follower rotation is not prevented during injection by a locking member that shifts by engagement with the syringe plunger, the mechanism may not meet the locking-member limitation.
2) No “first torsional then axial” behavior from the same dual-function element
- If unlatching is produced by a different actuator, or if axial retraction occurs simultaneously with unlatching rather than after unlatching as claimed, the “first… then…” functional sequencing may not read on.
3) No defined latching/unlatching elements between shuttle and follower
- If there is no first/second latching element pair that transitions from “latching position” to “unlatching position,” the claim’s delay mechanism core may not be met.
4) No damping compound
- If follower rotation is controlled without a damping compound between follower and supporting surface, literal correspondence to “damping compound” may be lacking.
5) If coiled spring geometry is required (claims 2-5)
- Implementations that use elastomer torsion elements, gas springs, leaf springs, or other multi-axis springs may avoid claims 2-5 even if they meet claim 1.
6) If locking member is not a flexure integrally formed with the follower (claim 7)
- Alternative locking architectures (separate parts, different kinematics, non-flexure members) reduce coverage for claim 7.
Claim chart style deconstruction (for infringement mapping)
| Claim limitation |
What the accused device must include |
Most direct design target |
| Automatic injection apparatus with housing, needle syringe, plunger, forward-driving biasing element |
Standard autoinjector architecture |
Needle extension + plunger injection stage |
| Shuttle with first latching element |
A component (shuttle) that holds position relative to follower via a latch |
A shuttle-mounted latch feature |
| Follower with second latching element |
A follower with complementary latch |
A follower-mounted latch surface |
| Latching limits shuttle relative motion (retraction direction) |
Engagement constrains relative motion opposite extension |
Prevents premature retraction |
| Locking member moves by engagement with syringe plunger during injection |
A plunger-actuated mover shifts locking to release |
Plunger engagement during injection |
| Locking member prevents follower rotation in locking position |
Followers rotation is blocked during injection |
Gate follower rotation |
| Locking member allows follower rotation in release position |
Rotation becomes possible after release |
Unlock rotation event tied to injection |
| Damping compound between follower and supporting surface |
A damping medium at rotation interface |
Controlled rotational damping |
| Dual-function biasing member with torsional + axial preloading |
Energy storage produces torsional and axial forces |
Single element does both functions |
| Torsional force unlatches follower from shuttle first |
Rotation triggers disengagement from latching position |
Unlatching step first |
| Axial force retracts shuttle after unlatching |
Retraction occurs after the unlatch event |
Retract step second |
| Coiled spring with ends engaging follower and shuttle (claims 2-5) |
Spring geometry and end engagement required |
Radial tip + recess; axial tip + recess |
| Supporting surface is collar fixed to housing (claim 6) |
Collar rotatably fixed structure |
Collar-based damping support |
| Locking member is follower-integral flexure engaged by plunger outrigger (claim 7) |
Flexure-kine tied to syringe outrigger |
Follower-integral flexure linkage |
| Retract biasing not resisted by forward biasing element (claim 8) |
Force path independence between phases |
Separate effective load paths |
US patent landscape (how this patent is positioned among autoinjector delay mechanisms)
1) Mechanical delay systems in autoinjectors are a repeat battleground
In the US, autoinjector patents often converge on:
- triggers tied to plunger movement
- retract mechanisms that avoid premature needle return
- energy storage elements that time events without external sensors
- latch/unlatch transitions and controlled motion damping
US 8,734,394 sits squarely in that space by combining:
- a plunger-actuated locking member that gates follower rotation
- a damping compound for rotational dynamics
- a single “dual functioning biasing member” that performs sequential unlatch then retract forces
2) The most defensible novelty is the sequencing coupling
From claim language alone, the strongest differentiator is the required actuation order and that the same dual-function biasing member performs both the torsional unlatching and subsequent axial retraction.
A large portion of autoinjector prior art tends to split timing functions across:
- separate springs or separate actuators for unlatching and retraction
- gating systems that do not require torsional-then-axial sequencing by a common element
3) Dependent claims carve out specific mechanical embodiments that could be widely adoptable
Claims 2-5 narrow to a coiled spring with tip-and-recess engagement, including:
- radially outward tip in follower through-opening recess
- axially extending tip in shuttle recess
- recess in radially projecting latch tab
Claims 6-8 further narrow to structural choices:
- collar support
- follower-integral flexures actuated by plunger outrigger
- decoupling retract biasing from forward-driving biasing resistance
This architecture typically defines:
- a broad independent claim on functional sequencing (claim 1)
- narrower “fallback” coverage on common implementation patterns (claims 2-8)
4) Enforcement posture implied by this claim set
Because claim 1 is written as a combination of multiple functional limitations (locking, damping, latching, dual preloading, and ordered torsional then axial action), the likely infringement posture is:
- strongest against devices that use a similar mechanical sequence with a plunger-actuated lock and a single torsion/axial spring element
- more limited reach against devices that swap in different delay hardware (different biasing element type, different unlatch timing, separate actuators)
What to look for in competitor designs to assess exposure
Using the claim constraints as an inspection checklist, competitor autoinjectors that could be closest to the patent will show:
- A two-part relative-motion mechanism with a follower and shuttle that latch and unlatch during operation
- A plunger-linked gate that prevents follower rotation for at least part of the injection stroke
- A damping compound in the follower rotation interface
- A spring element that simultaneously provides:
- torsional tendency to rotate the follower relative to the shuttle
- axial bias to move the shuttle after unlatching
- A kinematic path where:
1) unlatch event occurs after locking release
2) retraction follows after unlatch
Key Takeaways
- Claim 1 defines a timed autoinjector delay mechanism that gates follower rotation with a plunger-actuated locking member, uses damping compound to control rotational behavior, and relies on a dual-function biasing member that must drive unlatching first (torsion) and retraction second (axial).
- Claims 2-5 narrow the dual biasing member to a coiled spring with specific radial tip and axial tip recess interfaces tied to latch tab geometry.
- Claims 6-8 further narrow to a collar-based damping support, a follower-integral flexure locking member actuated by a syringe outrigger, and phase decoupling so retract biasing is not resisted by forward biasing.
- The most meaningful competitive risk cluster is devices that implement the same torsional-then-axial sequencing from the same energy storage element plus plunger-tied locking.
FAQs
1) Does claim 1 require the follower to unlatch before retraction starts?
Yes. Claim 1 states the biasing member first forces rotation to an unlatching position and then forces axial motion for retracting the needle.
2) Is the “dual functioning biasing member” required to be a coiled spring?
Not in claim 1. A coiled spring is required only in claim 2 and the dependent claims that specify spring-end geometry.
3) What role does the locking member play?
It prevents follower rotation in the locking position during injection and allows follower rotation only after moving to the release position during injection by engagement with the syringe plunger.
4) What does the damping compound limitation cover?
It requires a damping compound between the follower and a supporting surface to damp rotation of the follower relative to the shuttle.
5) Which claim most tightly defines the mechanical latch recess geometry?
Claim 5, by tying a shuttle recess to a radially projecting tab that comprises the first latching element.
References
[1] US Patent Application Publication / US Patent No. 8,734,394 (claim text provided by user).
